Rhophylac (CSL Behring AG)


Welcome to the PulseAid listing for the Rhophylac drug offered from CSL Behring AG. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: CSL Behring AG
NON-PROPRIETARY NAME: HUMAN RHO(D) IMMUNE GLOBULIN
SUBSTANCE NAME: HUMAN RHO(D) IMMUNE GLOBULIN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00


Rhophylac PLASMA DERIVATIVE Details:

Item DescriptionRhophylac from CSL Behring AG
LABELER NAME: CSL Behring AG
DEA SCHEDULE:
ACTIVE STRENGTH: 1500([iU]/2mL)
START MARKETING DATE: 2009-01-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44206-300_81aef654-4f74-4547-a259-d558b6869c54
PRODUCT NDC: 44206-300
APPLICATION NUMBER: BLA125070

Other HUMAN RHO(D) IMMUNE GLOBULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
CSL Behring AGRhophylac
GRIFOLS USA, LLCHYPERRHO
Kedrion Melville, Inc.RhoGAM Ultra-Filtered PLUS